Leidos Holdings, Inc. (LDOS): BCG Matrix [June-2026 Updated]

This ready-made BCG Matrix Analysis of Leidos Holdings, Inc. Business gives you a clear, practical view of where the portfolio is growing, where it is generating cash, and where capital is being deployed. You will see how AI-enabled national security, cloud modernization, mission software, and autonomous defense line up as growth areas, while core federal services, recurring civilian work, dividends, and buybacks support cash flow from $17.17B of 2025 revenue, $1.75B of operating cash flow, and 14.1% adjusted EBITDA margin; it also shows how the $2.4B ENTRUST acquisition, $350.0M 2026 capex plan, and contract wins like Cloud One, DISA, and SEC Evolve shape portfolio balance, market growth, relative scale, and capital allocation through 2026.

Leidos Holdings, Inc. - BCG Matrix Analysis: Stars

Leidos Holdings, Inc. fits the Star quadrant in several high-growth areas where it is winning large contracts, scaling technical capability, and raising revenue visibility. The strongest Star candidates are AI-enabled national security, cloud modernization, mission software, and autonomous defense expansion.

AI Enabled National Security is a clear Star because Leidos is building in a market where spending is rising and technical barriers are high. The January 22, 2026 OpenAI partnership and the May 2026 Protect AI collaboration strengthen its AI credentials, while Theodore Tanner Jr. becoming CTO on January 5, 2026 adds depth through 18 AI and machine-learning patents. The February 10, 2026 $142.0M DISA award for Compartmented Enterprise Services Office IT operations shows that these capabilities are already turning into funded federal work. The earlier $300.0M Kudu Dynamics acquisition also broadened offensive cyber and electromagnetic spectrum operations, which matters because those mission areas are harder to replicate and usually carry better pricing power.

This segment supports Star status because Leidos is not just experimenting with AI; it is tying AI to national security use cases where demand is large and durable. Management's raised 2026 revenue guidance of $18.0B-$18.4B shows that the company expects these capabilities to contribute to growth, not just cost control. In BCG terms, a Star needs both high market growth and strong position. Leidos is building both through contracts, acquisitions, and technical leadership.

Cloud Modernization Scale also fits the Star profile because the company is winning large, long-cycle government cloud and infrastructure programs. The $454.9M Cloud One award for the U.S. Air Force, the four functional categories under the $10.0B State Department Evolve contract, and the $284.0M 10-year SEC enterprise infrastructure deal show breadth across agencies and mission types. These are not one-off projects. They create a pipeline of implementation, migration, support, and follow-on work.

The booking data strengthens the case. Leidos reported $17.5B in 2025 net bookings, $5.6B in Q4 2025 bookings, and a 1.3 book-to-bill ratio. A book-to-bill above 1.0 means the company booked more business than it recognized as revenue, which usually supports future growth. That sits alongside companywide 2025 revenue of $17.17B and Q1 2026 revenue of $4.4B, up 4.0% year over year. For academic analysis, this is a useful example of how contract wins and book-to-bill data can signal Star momentum before full revenue shows up.

Mission Software Scale Up is another Star because Leidos is investing to grow in digital modernization and cyber while protecting margins. NorthStar 2030 names those areas as a core growth pillar, and management is backing it with $350.0M of 2026 capex. Capex, or capital expenditures, is money spent on long-term capacity such as systems, facilities, and technology. In this case, it signals that Leidos is funding growth rather than just harvesting existing contracts.

The profitability profile supports that growth story. Fiscal 2025 adjusted EBITDA was $2.42B with a 14.1% margin, and Q1 2026 adjusted EBITDA was $614.0M at a 14.0% margin. EBITDA means earnings before interest, taxes, depreciation, and amortization, so it is a common way to measure operating performance before financing and accounting charges. The company also had 50,000 employees in May 2026, up from 47,000 in early 2025. That increase matters because it shows Leidos is adding delivery capacity while keeping margins near 14%, which is a sign of disciplined scaling.

Autonomous Defense Expansion belongs in Stars because Leidos is moving into areas where defense spending is shifting toward speed, autonomy, and non-kinetic effects. On May 13, 2026, the company signed a framework agreement to build an initial 3,000 low-cost containerized munitions. On May 12, 2026, it also agreed to accelerate hypersonic weapons production for the U.S. Army and Navy. Those programs are important because they tie Leidos to mission-critical production, not just advisory work or software maintenance.

• Management said geopolitical demand for non-kinetic effects and autonomous systems is driving backlog growth.
• Leidos raised 2026 operating cash flow guidance to $1.8B.
• Fiscal 2025 operating cash flow was $1.75B.
• Leidos achieved 99% of revenue compensation targets.
• The company reached 110% of adjusted EBITDA and operating cash flow targets for fiscal 2025.

Those numbers matter because Star businesses usually need both demand and funding to keep expanding. Strong operating cash flow gives Leidos room to invest in production, software, and delivery systems without straining the balance sheet. A target beat of 110% on adjusted EBITDA and operating cash flow also suggests management is executing better than expected, which helps sustain growth in a high-demand segment.

Across these Star businesses, Leidos is combining large contract wins, rising revenue, and targeted investment. That is the core pattern you would expect in a Star quadrant: fast-growing markets, strong positioning, and enough scale to convert demand into measurable financial results.

Leidos Holdings, Inc. - BCG Matrix Analysis: Cash Cows

Leidos Holdings, Inc. fits the Cash Cow category because it combines large-scale federal service revenue with steady cash generation, disciplined capital return, and mature contract renewal patterns. The business is not dependent on explosive growth; it is built to convert a stable government workload into operating cash flow, dividends, and buybacks.

The core evidence is financial. Leidos produced $17.17B of revenue in 2025 and $1.75B of operating cash flow, up 22% year over year. Net income margin was 8.5%, while adjusted EBITDA reached $2.42B with a 14.1% margin. Management said it achieved 99% of the revenue compensation target and 110% of the adjusted EBITDA margin and operating cash flow targets for fiscal 2025. A 1.0 book-to-bill ratio for 2025, with 1.3 in Q4 2025, shows the company is replacing work at a steady pace rather than relying on one-time spikes.

The recurring civilian and homeland work base is another reason the company behaves like a Cash Cow. The $284.0M 10-year SEC award, the $142.0M DISA modernization award, and the $454.9M Cloud One contract point to durable federal service lines. Leidos also won four categories under the $10.0B State Department Evolve contract, which gives it broad exposure to long-cycle modernization programs. These contracts sit in Homeland and Intelligence and Digital work, where demand tends to repeat through renewals, task orders, and agency modernization spending rather than through fast commercial expansion.

• $17.5B in 2025 bookings supports future revenue visibility.
• $5.6B in Q4 bookings shows strong late-year pipeline conversion.
• Long-duration federal contracts reduce volatility and improve planning.
• Recurring modernization work supports margin stability and cash conversion.

Capital return is a major Cash Cow signal. The board declared a quarterly dividend of $0.43 per share, equal to $1.72 annually, and the reported dividend yield was 1.13%. Leidos also repurchased $200.0M of stock in Q1 2026 and reduced share count by 4.4% in 2025. Total shares outstanding were 126.39M, and buybacks contributed $0.50 to EPS. These actions are only possible because the company can fund them from operating cash flow instead of depending on external financing.

The cash math supports the classification. Operating cash flow of $1.75B is enough to fund dividends, buybacks, debt service, and selective investment while preserving balance sheet flexibility. Management raised 2026 operating cash flow guidance to $1.8B, which implies continued confidence in cash generation. In BCG terms, this is the profile of a mature business that throws off excess cash and does not need heavy reinvestment just to defend its position.

The balance sheet also supports a Cash Cow reading. Cash and equivalents were $1.1B against $4.6B of gross debt, and pro forma gross leverage was expected at 2.6x after the ENTRUST financing. Interest expense for 2026 is projected at $200.0M, which is manageable against a $17.17B revenue base. That means debt is a tool for acquisition and capital structure management, not a sign of stress.

Use this structure when writing about the Cash Cow position of Leidos Holdings, Inc.:

• Stable federal services create repeatable revenue.
• High operating cash flow shows strong conversion from earnings to cash.
• Book-to-bill near or above 1.0 supports backlog stability.
• Dividends and buybacks show excess cash is being returned to shareholders.
• Moderate leverage is manageable because cash flow is steady.

In BCG Matrix terms, Leidos Holdings, Inc. is a Cash Cow because it has a strong market position in mature government service areas, dependable contract demand, and enough free cash generation to fund capital returns without relying on high-growth reinvestment.

Leidos Holdings, Inc. - BCG Matrix Analysis: Question Marks

Leidos Holdings, Inc. has several business areas that fit the Question Mark quadrant because they sit in high-potential markets but do not yet show clear proof of dominant market share or fully visible returns. The key issue is the same across these areas: strong strategic intent, heavy capital use, and incomplete evidence that the investment will turn into a market-leading position.

Question Mark businesses need close monitoring because they can become Stars if they gain share, or they can stay costly if growth does not convert into scale. For Leidos Holdings, Inc., the main Question Marks are tied to energy infrastructure, managed health services, space and maritime, and AI venture investments.

Energy infrastructure buildout is a classic Question Mark because Leidos Holdings, Inc. made a large bet before the earnings outcome is fully visible. The company completed the $2.4B ENTRUST Solutions Group acquisition on March 30, 2026. Management said the deal doubled its presence in the utility market and pushed the strategy toward end-to-end energy infrastructure. That is a strong strategic signal, but it is not yet proof of market leadership.

The funding mix also shows how serious the commitment is: $500.0M cash, $500.0M commercial paper, and $1.4B of new bonds. At the same time, Leidos Holdings, Inc. planned to triple 2026 capital expenditures to $350.0M. High capex means the business must earn attractive returns to justify the spend. If revenue grows but margins stay weak, this area could remain a capital drain rather than a growth engine.

• $2.4B acquisition size raises the bar for integration execution.
• $350.0M planned capex signals aggressive scaling.
• Utility market expansion is promising, but the operating payoff is not yet fully proven.

Managed health services expansion also belongs in Question Marks because the strategy is visible, but the scale outcome is still unclear. Amy Wykoff joined on May 4, 2026 as Senior Vice President and Chief Product Officer for the Health sector, which is a newly created role. That matters because new leadership roles often signal that a company wants to build a sharper product and growth strategy, not just maintain the status quo.

NorthStar 2030 lists Managed Health Services as one of five growth pillars, so the business is being repositioned for expansion. But the Department of Veterans Affairs medical exams contract is expected to moderate through 2026, which reduces revenue visibility. Leidos Holdings, Inc. reported $17.17B of 2025 revenue and $4.4B of Q1 2026 revenue, yet health contribution was not disclosed separately. That makes it hard to judge whether the segment has enough scale to move from promise to leadership.

Space and maritime optionality is another Question Mark because it has strategic importance but limited public scale data. NorthStar 2030 names Space and Maritime as a core pillar, yet no June 2026 revenue contribution or market share was disclosed for that line. Without hard evidence on sales or share, you cannot place it in the high-share part of the BCG matrix.

Leidos Holdings, Inc. is still spending to support growth in adjacent mission areas. The company planned $350.0M of 2026 capex and expanded its classified-facility footprint, which points to more capacity for national security programs. Its workforce rose to about 50,000 employees from 47,000 in early 2025. That staffing increase shows readiness to support more work, but it does not prove that space and maritime programs have already reached scale. The only demand evidence mentioned is indirect, including geopolitical demand for autonomous systems and non-kinetic effects.

• Core pillar status suggests strategic priority.
• No disclosed segment revenue means market share is still opaque.
• Workforce growth supports capacity, not proven dominance.
• Indirect demand signals are not enough for a high-share classification.

AI venture investments are a Question Mark because the upside is real, but the monetization path is still uncertain. On May 29, 2026, Leidos Holdings, Inc. made a multiyear $100.0M strategic investment in a leading private equity firm to access disruptors in AI, cyber, and autonomy. This sits alongside the OpenAI partnership and Protect AI collaboration, which shows the company wants exposure to fast-moving technologies rather than relying only on traditional government contracting.

Still, no direct revenue contribution has been disclosed for the investment vehicle itself. Leidos Holdings, Inc. is also balancing that commitment against $350.0M of 2026 capex and a $200.0M share repurchase. That tells you capital is being spread across growth and shareholder returns at the same time. The company posted 4.0% Q1 2026 revenue growth and a 14.0% adjusted EBITDA margin, but companywide results do not prove that the AI lane can scale on its own.

• $100.0M strategic investment shows intent, not guaranteed payoff.
• AI, cyber, and autonomy are attractive themes, but revenue is not yet visible.
• 14.0% adjusted EBITDA margin supports financial capacity for experimentation.
• $200.0M repurchases show Leidos Holdings, Inc. is still balancing growth and capital returns.

In BCG terms, these businesses are not Dogs because they are not low-growth, low-share legacy units being harvested or exited. They are better treated as Question Marks because Leidos Holdings, Inc. is actively investing, expanding, and repositioning them, but the market share and return profile are still incomplete. The strategic question is whether each area can convert investment into durable scale fast enough to justify the capital committed.

Leidos Holdings, Inc. - BCG Matrix Analysis: Dogs

Leidos Holdings, Inc. has a few business lines that fit the Dog quadrant because they face slower growth, margin pressure, and weak visibility. These areas still produce revenue, but they need more management attention and capital than they are likely to return in the near term.

Shutdown-sensitive programs are a clear Dog-style exposure. A six-week U.S. government shutdown in late 2025 reduced quarterly revenue by about 4% on a normalized basis, which shows how dependent some programs are on federal budget timing rather than organic demand. Leidos still reported $17.5B in 2025 bookings and a 1.0 book-to-bill ratio, but that only shows order intake matched revenue, not that the portfolio has strong growth. The 9.35% stock drop in Q1 2026 after results also suggests investors saw these pressured lines as fragile. In BCG terms, that is a low-growth, low-resilience profile.

Fixed-price defense friction also belongs in the Dog category. Management said changing customer requirements could compress margins and delay fixed-price development programs in the Defense segment. That matters because fixed-price contracts put more risk on the contractor: if costs rise or schedules slip, profits can shrink fast. Leidos reported a Q1 2026 adjusted EBITDA margin of 14.0%, while 2025 net income margin was 8.5%, so there is not much cushion for mistakes. The company raised 2026 revenue guidance only to $18.0B-$18.4B, which signals moderate growth, not a breakout. It also plans to triple capex to $350.0M, showing the company must spend heavily just to keep the portfolio competitive.

• Fixed-price contracts can create upside only if execution is strong.
• When customer requirements change, margins can narrow fast.
• A 14.0% adjusted EBITDA margin leaves limited room for overruns.
• Higher capex of $350.0M can reduce free cash flow flexibility.

Veterans exams deceleration is another Dog-style area because slower growth in a large service contract can weaken overall mix. Analysts specifically flagged moderation in growth for the Department of Veterans Affairs medical exams contract through 2026. That matters because Leidos reported $4.4B in Q1 2026 revenue and 4.0% year-over-year growth, but it did not disclose a separate health growth rate that would offset the concern. The company's overall adjusted EBITDA margin of 14.0% is healthy, yet a mature contract with slowing demand still acts like a drag on future growth. In BCG terms, this is a business that may keep cash coming in, but not enough to justify aggressive reinvestment.

Legacy international overhang also leans toward Dog status. Adam Clarke became Chief Executive of Leidos U.K. & Europe on March 31, 2025, but no June 2026 growth or margin metrics were disclosed for that region. That lack of visible acceleration matters because Leidos is directing attention toward NorthStar 2030 pillars, AI, energy infrastructure, and national security scaling. With 2026 capex set at $350.0M and a $2.4B utility acquisition absorbing resources, older regional operations with no clear growth signal look secondary. Total workforce growth to 50,000 employees and 2026 revenue guidance of $18.0B-$18.4B are being driven elsewhere, which weakens the case for prioritizing legacy international units.

• No disclosed growth or margin data makes the region hard to underwrite.
• Management attention is shifting to AI, national security, and energy infrastructure.
• Capital is being pulled toward higher-priority initiatives.
• Without visible acceleration, the unit looks like a low-return asset.

For BCG purposes, the Dog label does not mean the unit is useless. It means the unit has low growth, limited strategic upside, or both, so it should receive disciplined capital allocation. In Leidos Holdings, Inc., these programs still matter because they support revenue stability and customer relationships, but they do not appear to be the main drivers of future expansion. That is why a student or analyst would place them in the Dog quadrant rather than Stars or Question Marks.